SND-113 series

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSND-113 series
Drug Alias NameSW-113 seriesanti-parasitic therapy (Snowdon/University of Chicago)SN-T18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCardiac myosin inhibitors
TargetsCardiac myosin
Therapy Area/IndicationsToxoplasmosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSnowdon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSnowdon
Active IndicationsN/A
Inactive IndicationsToxoplasmosis

Other Information

ATC CodeN/A
Related LinksN/A